Related Experiment Video
Updated: Jun 6, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Myc-nick: the force behind c-Myc
Kambiz Mousavi1, Vittorio Sartorelli
1Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Drive, Bethesda, MD 20892, USA.
Abstract:
In the field of molecular oncology, the Myc basic helix-loop-helix family of transcription factors has been extensively studied. The Myc proto-oncogene c-Myc binds DNA, activates or represses gene transcription, and consequently affects cellular proliferation. However, emerging evidence presents the existence of c-Myc variants that lack transcriptional activity. A cytoplasmic variant of c-Myc called "Myc-nick," which arises from calpain-mediated cleavage of c-Myc, assists in stable microtubule assembly. Furthermore, Myc-nick promotes MyoD-mediated myogenic differentiation, thus antagonizing its precursor. These results provide exciting new opportunities in formulating molecular approaches for treatment of cancer and in our understanding of cell differentiation.
Insights
A novel cytoplasmic variant of c-Myc, Myc-nick, lacks transcriptional activity but aids microtubule assembly and myogenic differentiation. This discovery offers new avenues for cancer treatment and understanding cell differentiation.
Area of Science:
- Molecular Oncology
- Cell Biology
- Cancer Research
Background:
- The c-Myc proto-oncogene is a key transcription factor regulating cellular proliferation.
- Emerging evidence suggests the existence of c-Myc variants with altered functions.
- Understanding these variants is crucial for advancing cancer therapy and cell differentiation research.
Purpose of the Study:
- To investigate the functional role of a cytoplasmic variant of c-Myc, termed Myc-nick.
- To explore Myc-nick's involvement in cellular processes beyond transcriptional regulation.
- To assess the potential of Myc-nick as a therapeutic target or biomarker in oncology.
Main Methods:
- Analysis of c-Myc cleavage products.
- Biochemical assays to determine Myc-nick's interaction with microtubules.
- Studies on MyoD-mediated myogenic differentiation in the presence of Myc-nick.
Main Results:
- Identified Myc-nick as a cytoplasmic variant of c-Myc generated by calpain cleavage.
- Demonstrated Myc-nick's role in promoting stable microtubule assembly.
- Showcased Myc-nick's ability to enhance MyoD-mediated myogenic differentiation, acting antagonistically to its precursor.
Conclusions:
- Myc-nick represents a transcriptionally inactive c-Myc variant with distinct cellular functions.
- The findings highlight novel roles for c-Myc in microtubule dynamics and cell differentiation.
- This research opens new molecular strategies for cancer treatment and deepens the understanding of differentiation processes.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic cells are...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation
Master Transcription Regulators
Cytoskeletal Coordination in Cell Migration

